Zu den Inhalten springen

Klinik für Psychiatrie und Psychotherapie

Research group Fiebich

Neurochemistry and Neuroimmunology
Research group
Dr. Bernd Fiebich
Phone: +49 (0)761 270 - 68980
Email: bernd.fiebich@uniklinik-freiburg.de
Group members: Dr. Inga Herpfer (M.D.)
Nizar Yousif (Ph.D.)
Soraya Wilke Saliba (Ph.D.)
Florian Ferver (M.D. student)
Matthias Apweiler (M.D. student)

We are frequently offering , M.D. theses (med. Doktorarbeiten), Internships / Master / Diploma Thesis positions.
For more informations, please contact: bernd.fiebich@uniklinik-freiburg.de

Research focus

Our research group is interested in various aspects of neuroinflammtion and neurodegeneration related to aging.
We are studying in detail the arachidonic acid cascade in microglia with a focus on Prostaglanin E2/D2 and the enzymes involved in their synthesis (COX, mPGES, PGDS).
Another major focus of our group is the role of miRNAs in neuroinflammation, neurodegeneration and peripheral blood cells (monocytes, lymphocytes, thrombocytes).
We also investigate the effects of conventional psychotropic drugs on tachykininergic systems as well as the effects of tachykinin receptor antagonists on monoaminergic neurotransmission and on behaviour in mice.

Research projects

  • Neuroinflammation
  • Psychoneuroendocrinology
  • Alzheimer’s disease and neurodegeneration


  • miRNA: Dr. C. Stratz/Dr. T. Nuehrenberg (University Heart Center Bad Krozingen), Dr. A Höllig (University Hospital Aachen) 
  • Nutrition and healthy aging: Prof. M. Huell (ZFP Emmendingen), Dr. G. Eckert (University of Frankfurt) 
  • Tachykinergic systems: Prof. K. Lieb (Department of Psychiatry and Psychotherapy, University Medical Centre Mainz), Prof. N. Singewald (Neuropharmacology, University of Innsbruck, Austria)
  • Neuroinflammation and Neurodegeneration (Prof. Eduardo Munoz (University of Cordoba, Spain), Prof. Antonio de Oliveira (University of Belo Horizonte, Brasil), Prof. Eduardo Candelario-Jalil (University of Florida, Gainesville, Florida, USA).

Selected recent papers

  • Alleviation of Microglial Activation Induced by p38 MAPK/MK2/PGE2 Axis by Capsaicin: Potential Involvement of other than TRPV1 Mechanism/s. Bhatia HS, Roelofs N, Muñoz E, Fiebich BL. Sci Rep. 2017 Dec;7(1):116.  
  • Bhatia HS, Baron J, Hagl S, Eckert GP, Fiebich BL. Rice bran derivatives alleviate microglia activation: possible involvement of MAPK pathway. J Neuroinflammation. 2016 Jun 14;13(1):148.
  • de Oliveira AC, Yousif NM, Bhatia HS, Hermanek J, Huell M, Fiebich BL. Poly(I:C) increases the expression of mPGES-1 and COX-2 in rat primary microglia. J. Neuroinflammation. 2016 Jan 18;13(1):11. doi: 10.1186/s12974-015-0473-7.
  • Kumar A, Bhatia HS, de Oliveira AC, Fiebich BL. microRNA-26a modulates inflammatory response induced by toll-like receptor 4 stimulation in microglia. J Neurochem. 2015 Dec;135(6):1189-202. doi: 10.1111/jnc.13364.  
  • Nizar M. Yousif, Antonio Carlos Pinheiro de Oliveira, Simone Brioschi, Michael Huell, Knut Biber and Bernd L. Fiebich. Activation of EP2 receptor suppresses Poly(I:C) and LPS-mediated inflammation in primary microglia and organotypic hippocampal slice cultures: Contributing role for  MAPKs, GLIA 2017 (in press).  
  • Saliba SW, Vieira EL, Santos RP, Candelario-Jalil E, Fiebich BL, Vieira LB, Teixeira AL, de Oliveira AC. Neuroprotective effects of intrastriatal injection of rapamycin in a mouse model of excitotoxicity induced by quinolinic acid. Journal of Neuroinflammation, v.14, p.25, 2017.

Publications in PubMed


  • Alzheimer Foundation (AFI): MikroRNS Profilierung von Monozyten von Alzheimer-Patienten
  • BMWi/AIF: AGEsense: Determination, function, and pharmaclogical intervention of the synthesis of Advanced Glycation End Products (AGEs)
  • BMBF (TUNGER-36): Cooperation project with the University of Sfax, Tunisia: Mechanism- based approaches for improved health risk assessment of synthetic pyrethroids in the CNSD

Klinik für Psychiatrie und Psychotherapie

Hauptstraße 5
79104 Freiburg

Information: 0761 270-65010

Informationen für den Umgang mit psychischen Belastungen im Zusammenhang mit der 'Corona-Krise'

Hier finden Sie eine Auswahl von Empfehlungen, die sich bei der Bewältigung besonderer Belastungen bewährt haben.

CORONA-Krise - Online-Unterstützung für Patienten mit Depression

Betroffene können sich formlos über die E-Mail-Adresse ifightdepression@deutsche-depressionshilfe.de für das Online-Programm iFightDepression anmelden und werden innerhalb von 24 Stunden freigeschaltet.

Aktuelle Weiterbildung

PPA-Symposium 19.09.2020 "Psychiatrie und Psychotherapie – aktuell" (Infos und Anmeldung)